<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03428633</url>
  </required_header>
  <id_info>
    <org_study_id>AsklepieionVGH</org_study_id>
    <nct_id>NCT03428633</nct_id>
  </id_info>
  <brief_title>Thoracic Paravertebral Blocks in Open Nephrectomy</brief_title>
  <official_title>Thoracic Paravertebral Blocks in Open Nephrectomy. A Prospective, Randomized Study of Block Efficacy and Influence on Oxidative Stress and Patient Outcome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asklepieion Voulas General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Michail Tsagkaris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chryssoula Staikou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ioannis Karavokyros</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asklepieion Voulas General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      60 patients ASA I-III, undergoing open nephrectomy will be randomly assigned into one of two
      groups, namely group A (n=30), where a thoracic paravertebral block will be performed
      preoperatively and a paravertebral catheter for continuous and patient controlled bolus local
      anesthetic (ropivacaine) doses will be inserted and group B (n=30) where morphine IV will be
      administered at the beginning and the end of operation and postoperatively through patient
      controlled IV doses. NRS scores in static and dynamic conditions, complications, patient
      satisfaction, oxidative stress (through lactic acid, superoxide dismutase, malondialdehyde)
      and NGAL pre- and postoperatively, will be recorded.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2018</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>48 hours</time_frame>
    <description>Numerical Rating Scale (NRS) scores (Range 0-10, 0=no pain, 10=the worse pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative stress - lactic acid (mmol/L)</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative stress - superoxide dismutase (units/ml)</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative stress - malondialdehyde (nmol/mg protein)</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative stress - neutrophil gelatinase-associated lipocalin (NGAL) (ng/ml)</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>48 hours</time_frame>
    <description>Patients asked whether they would choose the same anaesthetic management in a future operation: Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient mobilization</measure>
    <time_frame>7 days</time_frame>
    <description>Patient reporting time of first standing to the side of the bed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal function</measure>
    <time_frame>7 days</time_frame>
    <description>Time of first passing of rectal gas, reported by the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic pain</measure>
    <time_frame>6 months</time_frame>
    <description>Using of Graded Chronic Pain Scale (GCPS) Grade 0: No pain in prior 6 months Grade 1: Low Intensity - Low Disability Grade II: High Intensity Characteristic Pain Intensity - Low Disability Grade III: High Disability - Moderately Limiting Grade IV: High Disability - Severely Limiting</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nephrectomy</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic paravertebral block using ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Morphine IV</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Paravertebral block using ropivacaine preoperatively and postoperatively</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Morphine intraoperatively and postoperatively</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physical status according to American Society of Anesthesiologists (ASA) I-III

          -  Patients scheduled for open nephrectomy

        Exclusion Criteria:

          -  Previous operation on same kidney

          -  Contraindication of paravertebral block or any of the agents used in the protocol

          -  BMI above 32

          -  Any concurrent malignancy not cured

          -  Serious psychiatric, mental and cognitive disorders

          -  Block failure

          -  Chronic pain

          -  Severe kidney disfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alexandros Makris</last_name>
    <phone>+306947076446</phone>
    <email>makrisalexandros@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michail Tsagkaris</last_name>
    <phone>+306949807469</phone>
    <email>michalistsagkaris@gmail.com</email>
  </overall_contact_backup>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2018</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asklepieion Voulas General Hospital</investigator_affiliation>
    <investigator_full_name>Alexandros Makris</investigator_full_name>
    <investigator_title>Consultant Anaesthesiologist</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

